Arete Wealth Advisors’s Immunomedics Inc IMMU Stock Holding History

Arete Wealth Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,800	Closed	-$408K	–	457
2020 Q3	$408K	Buy	+4,800	New	+$243K	0.06%	246

Arete Wealth Advisors's IMMU Position: Q4 2020 in Review

Arete Wealth Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,800 shares — an estimated $408K sold.

Arete Wealth Advisors first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $408K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Arete Wealth Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Arete Wealth Advisors sold 4,800 Immunomedics Inc shares in Q4 2020, an estimated $408K.
Arete Wealth Advisors first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Arete Wealth Advisors's Immunomedics Inc position peaked at $408K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Arete Wealth Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.